Cargando…

Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study

AIMS: The VEGAS study was conducted to evaluate representative data of de novo insulin-treated older patients with type 2 diabetes in the outpatient setting in Germany. METHODS: In this prospective, multicenter, non-interventional observational study, a nationwide written survey was carried out amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeyfang, Andrej, Patzelt-Bath, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883201/
https://www.ncbi.nlm.nih.gov/pubmed/27747621
http://dx.doi.org/10.1007/s40801-015-0014-9
_version_ 1782434229897920512
author Zeyfang, Andrej
Patzelt-Bath, Andrea
author_facet Zeyfang, Andrej
Patzelt-Bath, Andrea
author_sort Zeyfang, Andrej
collection PubMed
description AIMS: The VEGAS study was conducted to evaluate representative data of de novo insulin-treated older patients with type 2 diabetes in the outpatient setting in Germany. METHODS: In this prospective, multicenter, non-interventional observational study, a nationwide written survey was carried out among practitioners (02/2011–06/2011). Older patients, aged ≥70 years, starting de novo insulin therapy, were documented. RESULTS: Data from 4,858 patients from about 500 centers (mean age: 78.2 ± 5.4 years; mean glycosylated hemoglobin [HbA(1c)]: 70 ± 14.2 mmol/mol [8.6 ± 1.3 %]) were collected. The mean target HbA(1c) value was 55 ± 6.6 mmol/mol (7.2 ± 0.6 %). 91.1 % of geriatric patients were multi-morbid. 96.2 % showed at least one physical or psychological geriatric syndrome. Most of the patients were notably impaired according to their age. Conventional insulin therapy and basal-supported oral therapy were the most frequently planned treatment regimens (39.1 and 31.1 %). Important factors in the selection of the insulin treatment regimen were an efficient HbA(1c) decrease (65.6 %), easy administration (55.7 %), and also a patient’s ability to self-administer insulin (38.5 %). De novo insulin treatment increased care requirements (22.7 %). 22.3 % of the relatives were scheduled to receive special training. Specific training programs for older patients with diabetes were planned in only 7.3 % of cases. CONCLUSIONS: The data demonstrate the high prevalence of geriatric syndromes during de novo insulin treatment. Individual therapeutic goals and regimes are based on practicability, in particular, the receipt of autonomy and the care requirement. Diabetes education with adapted programs is currently under-represented. Important factors for the choice of an insulin treatment regimen were an efficient HbA(1c) decrease, easy administration, and a patient’s ability for self-administration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40801-015-0014-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4883201
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-48832012016-08-19 Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study Zeyfang, Andrej Patzelt-Bath, Andrea Drugs Real World Outcomes Original Research Article AIMS: The VEGAS study was conducted to evaluate representative data of de novo insulin-treated older patients with type 2 diabetes in the outpatient setting in Germany. METHODS: In this prospective, multicenter, non-interventional observational study, a nationwide written survey was carried out among practitioners (02/2011–06/2011). Older patients, aged ≥70 years, starting de novo insulin therapy, were documented. RESULTS: Data from 4,858 patients from about 500 centers (mean age: 78.2 ± 5.4 years; mean glycosylated hemoglobin [HbA(1c)]: 70 ± 14.2 mmol/mol [8.6 ± 1.3 %]) were collected. The mean target HbA(1c) value was 55 ± 6.6 mmol/mol (7.2 ± 0.6 %). 91.1 % of geriatric patients were multi-morbid. 96.2 % showed at least one physical or psychological geriatric syndrome. Most of the patients were notably impaired according to their age. Conventional insulin therapy and basal-supported oral therapy were the most frequently planned treatment regimens (39.1 and 31.1 %). Important factors in the selection of the insulin treatment regimen were an efficient HbA(1c) decrease (65.6 %), easy administration (55.7 %), and also a patient’s ability to self-administer insulin (38.5 %). De novo insulin treatment increased care requirements (22.7 %). 22.3 % of the relatives were scheduled to receive special training. Specific training programs for older patients with diabetes were planned in only 7.3 % of cases. CONCLUSIONS: The data demonstrate the high prevalence of geriatric syndromes during de novo insulin treatment. Individual therapeutic goals and regimes are based on practicability, in particular, the receipt of autonomy and the care requirement. Diabetes education with adapted programs is currently under-represented. Important factors for the choice of an insulin treatment regimen were an efficient HbA(1c) decrease, easy administration, and a patient’s ability for self-administration. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40801-015-0014-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-02-24 /pmc/articles/PMC4883201/ /pubmed/27747621 http://dx.doi.org/10.1007/s40801-015-0014-9 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Research Article
Zeyfang, Andrej
Patzelt-Bath, Andrea
Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title_full Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title_fullStr Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title_full_unstemmed Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title_short Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study
title_sort importance of geriatric syndromes in older patients with diabetes with de novo insulin treatment: the vegas study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883201/
https://www.ncbi.nlm.nih.gov/pubmed/27747621
http://dx.doi.org/10.1007/s40801-015-0014-9
work_keys_str_mv AT zeyfangandrej importanceofgeriatricsyndromesinolderpatientswithdiabeteswithdenovoinsulintreatmentthevegasstudy
AT patzeltbathandrea importanceofgeriatricsyndromesinolderpatientswithdiabeteswithdenovoinsulintreatmentthevegasstudy